Tag Archives: Recombinant Human Parathyroid Hormone Market

Recombinant Human Parathyroid Hormone Market Demand Analysis, Forecast – 2029

Recombinant Human Parathyroid Hormone is an artificially manufactured form of the parathyroid hormone used to treat hypoparathyroidism. Recombinant human parathyroid hormone is used in the treatment of osteoporosis in postmenopausal women at high risk of osteoporotic fractures. A significant reduction in the incidence of vertebral fractures has been demonstrated. Recombinant Human Parathyroid Hormone market size […]